Novo CEO pressed by Senate to cut price ranges of obesity, diabetic issues medication CEO Lars Fruergaard Jørgensen told lawmakers the company would consider new talks with insurers in regards to the checklist rates of Wegovy and copyright whenever they pledge to keep the medicines on their formularies.Earlier this summer season, the agency held l… Read More